Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UBS cuts Capgemini stock rating, expects Q1 growth to hit 'lowest point'

EditorEmilio Ghigini
Published 02/22/2024, 04:47 AM
Updated 02/22/2024, 04:47 AM
© Reuters.

On Thursday, UBS adjusted its stance on Capgemini SE (CAP:FP) (OTC: CAPMF), downgrading the stock from Buy to Neutral despite raising the price target to €235 from the previous €209. The firm cited management's expectations that growth will hit its lowest point in Q1 but will recover to a mid-to-high single-digit rate by the end of 2024, setting up for a strong 2025 based on a "soft landing scenario."

Capgemini concluded 2023 with a 5% reduction in its workforce compared to the beginning of the year and a 3% decrease from its average headcount over the year. This marks the first such reduction since 2009. UBS acknowledged the various factors affecting growth, such as the onshore-offshore mix, utilization, and subcontracting, but emphasized headcount as a crucial element.

The company's guidance for an organic growth rate between 0 and 2% for 2024 is deemed reasonable by UBS, but this growth is expected to be more pronounced in the second half of the year. Management's commitment to achieving a 14% margin by 2025, which would require a 70 basis point increase over two years, leads UBS to anticipate cautious recruitment and growth management in 2025 to maintain utilization rates and gross margin progression.

UBS's growth estimate for Capgemini in 2025 stands at 5.4%, which is below the consensus estimate of 6.9%. The firm's decision to downgrade comes as Capgemini's shares are trading at a 17.7x 12-month forward P/E ratio, surpassing the 10-year average of 16.0x, and a 5.2% free cash flow yield compared to the 10-year average of 7.1%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.